Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling

Weissmueller, Susann, Manchado, Eusebio, Saborowski, Michael, Morris, John P., Wagenblast, Elvin, Davis, Carrie A., Moon, Sung-Hwan, Pfister, Neil T. +10 more·2014·Cell

DOI 10.1016/j.cell.2014.01.066

Cited by (470)

Items 301–400 of 470

Emerging Prognostic and Predictive Factors in Pancreatic Cancer
Eva Karamitopoulou · 2023 · Modern Pathology
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells
Stefania Moz, Daniela Basso, Dania Bozzato, Paola Galozzi, Filippo Navaglia, Ola H. Negm, Giorgio Arrigoni, Carlo‐Federico Zambon, Andrea Padoan, Patrick J. Tighe et al. · 2016 · Oncotarget
Transcriptomic profile reveals molecular events associated to focal adhesion and invasion in canine mammary gland tumour cell lines
Yonara de Gouveia Cordeiro, Pedro Luiz Porfírio Xavier, Arina Lázaro Rochetti, Pâmela A. Alexandre, Cláudia Madalena Cabrera Mori, Ricardo de Francisco Strefezzi, Heidge Fukumasu · 2017 · Veterinary and Comparative Oncology
Establishment of a human primary pancreatic cancer mouse model to examine and investigate gemcitabine resistance
Ya-Jing Zhang, Chenlei Wen, Yuxin Qin, Xiao-Mei Tang, Min-Min Shi, Boyong Shen, Yuan Fang · 2017 · Oncology Reports
Functional and transcriptomic analyses of the NF-Y family provide insights into the defense mechanisms of honeybees under adverse circumstances
Guilin Li, Hang Zhao, Hongbin Guo, Ying Wang, Xuepei Cui, Baohua Xu, Xingqi Guo · 2020 · Cellular and Molecular Life Sciences
Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic
Yolanda Rodrı́guez Gil, Paula Jiménez Sánchez, Raúl Muñoz Velasco, Ana García García, Victor Javier Sanchez-Arevalo Lobo · 2021 · International Journal of Molecular Sciences
Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options
Chaoying Qin, Meng Huang, Yimin Pan, Yuzhe Li, Wenyong Long, Qing Liu · 2021 · Brain Tumor Pathology
One-shot dual gene editing for drug-resistant pancreatic cancer therapy
Eun-Jeong Won, Hyeji Park, Seung-Hee Chang, Jin Hyun Kim, Hojeong Kwon, Young‐Seok Cho, Tae‐Jong Yoon · 2021 · Biomaterials
Proteasome regulators in pancreatic cancer
Nirosha J. Murugan, Ioannis A. Voutsadakis · 2022 · World Journal of Gastrointestinal Oncology
Challenges and Opportunities Associated With Platelets in Pancreatic Cancer
Zhou Chen, Xiaodong Wei, Shi Dong, Fangfang Han, Ru He, Wence Zhou · 2022 · Frontiers in Oncology
Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor
Hye Min Kim, Yu Kyung Lee, Ja Seung Koo · 2016 · Disease Markers
Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer
Diego J. Jiménez, Aadil Javed, Teresa Rubio‐Tomás, Ndioba Seye-Loum, Carles Barceló · 2024 · International Journal of Molecular Sciences
Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer
Robert Słotwiński, Sylwia Małgorzata Słotwińska · 2017 · Central European Journal of Immunology
LncRNA Hmrhl regulates expression of cancer related genes in chronic myelogenous leukemia through chromatin association
Subhendu Roy Choudhury, Sangeeta Dutta, Utsa Bhaduri, Manchanahalli R. Satyanarayana Rao · 2021 · NAR Cancer
Anoikis-Related Gene Signature for Prognostication of Pancreatic Adenocarcinoma: A Multi-Omics Exploration and Verification Study
Jin Zhang, Xuesong Li, Yi Lu, Guowen Wang, Ying Ma · 2023 · Cancers
Effects of siRNA-mediated HIF-1α gene silencing on angiogenesis in osteosarcoma
Xu-dong Zhang, Qiang Wu, Shuhua Yang · 2017 · Pakistan Journal of Medical Sciences
Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC)
Jessica L.S. Zylla, Mariah Hoffman, Simona Plesselova, Somshuvra Bhattacharya, Kristin Calar, Yohannes Afeworki Tecleab, Pilar de la Puente, Etienne Z. Gnimpiéba, W. Keith Miskimins, Shanta M. Messerli · 2022 · Cancers
Identification of target genes in cancer diseases using protein–protein interaction networks
Arumugam Amala, Isaac Arnold Emerson · 2019 · Network Modeling Analysis in Health Informatics and Bioinformatics
Inhibitor of CBP Histone Acetyltransferase Downregulates p53 Activation and Facilitates Methylation at Lysine 27 on Histone H3
Adam S. Vincek, J. A. Patel, Anbalagan Jaganathan, Antonia Green, Valerie Pierre-Louis, Vimal Arora, Jill P. Rehmann, Mihaly Mezei, Ming‐Ming Zhou, Michael H. J. Ohlmeyer et al. · 2018 · Molecules
Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses
Diangeng Li, Peng Wang, Yi Yu, Bing Huang, Xuelin Zhang, Chou Xu, Xian Zhao, Zhiwei Yin, Zheng He, Meiling Jin et al. · 2018 · PeerJ
Nickel’s Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs
Maria Mortoglou, Luka Manić, Aleksandra Buha Djordjević, Zorica Bulat, Vladimir Đorđević, Katherine Manis, Elizabeth Valle, Lauren York, David Wallace, Pinar Uysal Onganer · 2022 · Toxics
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations
Matteo Canale, Elisabetta Petracci, Paola Cravero, Marita Mariotti, Gabriele Minuti, Giulio Metro, Vienna Ludovini, Sara Baglivo, Maurizio Puccetti, Alessandra Dubini et al. · 2022 · Translational Oncology
A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma
Casper W.F. van Eijck, Willem de Koning, Fleur van der Sijde, Miranda Moskie, Bas Groot Koerkamp, Marjolein Y.V. Homs, Sjoerd H. van der Burg, Casper H.J. van Eijck, Dana A. M. Mustafa · 2022 · European Journal of Cancer
Targeting the mutant p53 secretome
Kartik Sehgal, David Allen Barbie · 2021 · Journal of Clinical Investigation
Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma
Ziba Lotfi, Shiva Najjary, Fariba Lotfi, Mohammad Ali Amini, Amir Baghbanzadeh, Darya Javad Rashid, Elmira Roshani Asl, Behzad Baradaran, Ahad Mokhtarzadeh · 2021 · European Journal of Pharmacology
NF-Y Subunits Overexpression in HNSCC
Eugenia Bezzecchi, Andrea Bernardini, Mirko Ronzio, Claudia Miccolo, Susanna Chiocca, Diletta Dolfini, Roberto Mantovani · 2021 · Cancers
Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties
McCubrey, James A., Meher, Akshaya K., Akula, Shaw M., Abrams, Stephen L., Steelman, Linda S., LaHair, Michelle M., Franklin, Richard A., Martelli, Alberto M., Ratti, Stefano, Cocco, Lucio et al. · 2022 · Aging
p53 Down Regulates PDGF-Induced Formation of Circular Dorsal Ruffles in Rat Aortic Smooth Muscle Cells
Laura J. Payne, Robert Leo Eves, Lilly Jia, Alan S. Mak · 2014 · PLoS ONE
Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma
Yuji Kumakura, Susumu Rokudai, Misaki Iijima, Bolag Altan, Tomonori Yoshida, Halin Bao, Takehiko Yokobori, Makoto Sakai, Makoto Sohda, Tatsuya Miyazaki et al. · 2017 · Cancer Science
Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy
Bayan A. Al-Share, Nour Hammad, Maria Diab · 2021 · Cancer and Metastasis Reviews
Molecular Targeting of the Most Functionally Complex Gene in Precision Oncology: p53
Douglas W. Brown, Perrin H. Beatty, John D. Lewis · 2022 · Cancers
In Vitro Study of Colon Cancer Cell Migration Using E‐Jet 3D Printed Cell Culture Platforms
Juchang Zhong, Yingjie Zhang, Jingfei Chen, Ruiying Huang, Yikun Yang, Haoxiang Chen, Yuan Huang, Weihong Tan, Zhikai Tan · 2018 · Macromolecular Bioscience
Mutant p53: evolving perspectives
Gizem Efe, Katherine M. Cunningham, Anil K. Rustgi, Carol L. Prives, James J. Manfredi, Francisco J. Sánchez Rivera · 2025 · Genes & Development
A quantitative score of immune cell infiltration predicts the prognosis in pancreatic ductal adenocarcinoma
Zhigang Chen, Yun Wang, William Pat Fong, Ming-tao Hu, Jie‐Ying Liang, Lingyun Wang, Yuhong Li · 2021 · International Immunopharmacology
Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism
Shani Journo, Anat Klein Goldberg, Ethan S. Sokol, Lotem Zinger, Metsada Pasmanik, Boris A. Sarvin, Dor Simkin, Sivan Fuchs, Tomer Shlomi, Ido Wolf et al. · 2022 · Oncogene
Multimodal Imaging of Pancreatic Cancer Microenvironment in Response to an Antiglycolytic Drug
Elnaz Sheikh, Kirti Agrawal, Sanjit Kumer Roy, David H. Burk, Fabrizio Donnarumma, Young H. Ko, Praveen Kumar Guttula, Nrusingh C. Biswal, Hem Dutt Shukla, Manas Ranjan Gartia · 2023 · Advanced Healthcare Materials
Ligand-based computational modelling of platelet-derived growth factor beta receptor leading to new angiogenesis inhibitory leads
Rua'a Al‐Aqtash, Malek Zihlif, Hana M. Hammad, Zeyad D. Nassar, Jehad Al Meliti, Mutasem O. Taha · 2017 · Computational Biology and Chemistry
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals
Saverio Candido, Stephen Lee Abrams, Linda S. Steelman, Kvin Lertpiriyapong, Alberto Maria Martelli, Lucio Cocco, Stefano Ratti, Matilde Y. Follo, Ramiro Mendonça Murata, Pedro Luiz Rosalen et al. · 2019 · Advances in Biological Regulation
Reprogramming Enhancers to Drive Metastasis
Raúl Mostoslavsky, Nabeel M. Bardeesy · 2017 · Cell
Revealing the impact of autophagy-related genes in rheumatoid arthritis: Insights from bioinformatics
Xin Li, Shuang Ding, Pengcheng Zhang, Jing Yan, Xingxing Yu, Xukai Wang, Hongsheng Zhan, Zhengyan Wang · 2024 · Heliyon
Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives
Ari Hashimoto, Shigeru Hashimoto · 2024 · Cancers
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence
Kaloyan M. Tsanov, Francisco M. Barriga, Yu-Jui Ho, Direna Alonso‐Curbelo, Geulah Livshits, Sha Tian, Richard P. Koche, Timour Baslan, Janelle M. Simon, Alexandra N. Wuest et al. · 2025 · Nature Cancer
TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
Yiran Zhou, Jiabin Jin, Yuchen Ji, Jiaqiang Zhang, Ningzhen Fu, Mengmin Chen, Jun Wang, Kai Qin, Yu Jiang, Dongfeng Cheng et al. · 2023 · Journal of Translational Medicine
Pan-cancer analysis of non-coding recurrent mutations and their possible involvement in cancer pathogenesis
Chie Kikutake, Minako Yoshihara, Mikita Suyama · 2021 · NAR Cancer
Genetic Alterations Predict Long-Term Survival in Ductal Adenocarcinoma of the Pancreatic Head
Sami Alexander Safi, Lena Häberle, Wolfgang Goering, Verena Keitel, Georg Fluegen, Nikolas Hendrik Stoecklein, Alexander Rehders, Wolfram Trudo Knoefel, Iréne Esposito · 2022 · Cancers
TP53 missense–specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer
Laura Urbach, Lena Wieland, Frederike Penz, Rebecca Diya Samuel, Stefan Küffer, Lukas Klein, Christof Lenz, Ulrich Sax, Michael B. Ghadimi, Ramona Schulz‐Heddergott et al. · 2025 · Science Advances
Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells
Maria Poles, Raffaella Pacchiana, Chiara Mortali, Barbara Cisterna, Nidula Mullappilly, Adriana Celesia, Federica Danzi, Martina Gaspari, Daniela Cecconi, Massimo Donadelli et al. · 2025 · FEBS Journal
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status
Javier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia, Nicholas James Clemons, Kenji Mark Fujihara, Thomas Riseborough, Amina F.A.S. Teunisse, Aart G. Jochemsen, Lars Abrahmsén, Giovanni Blandino et al. · 2022 · Cancers
Effect of TP53 deficiency and KRAS signaling on the bioenergetics of colon cancer cells in response to different substrates: A single cell study
James T. Kealey, Heiko Düßmann, Irene Llorente‐Folch, Natalia Niewidok, Manuela Salvucci, Jochen H.M. Prehn, Beatrice D’Orsi · 2022 · Frontiers in Cell and Developmental Biology
Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma
Ari Hashimoto, Haruka Handa, Soichiro Hata, Shigeru Hashimoto · 2022 · Frontiers in Oncology
Molecular Imaging with MRI: Potential Application in Pancreatic Cancer
Chen Chen, Chang Qiang Wu, Tian Wu Chen, Meng Yue Tang, Xiao Ming Zhang · 2015 · BioMed Research International
HNF-1a promotes pancreatic cancer growth and apoptosis resistance via its target gene PKLR
Zhiyao Fan, Kun Fan, Shengming Deng, Yitao Gong, Yunzhen Qian, Qiuyi Huang, Chao Yang, Cheng He, Kaizhou Jin, Guopei Luo et al. · 2020 · Acta Biochimica et Biophysica Sinica
Pancreatic cancer: genetics, disease progression, therapeutic resistance and treatment strategies
Karnika Singh, Gauri Shishodia, Hari K. Koul · 2021 · Journal of Cancer Metastasis and Treatment
A recent update on the connection between dietary phytochemicals and skin cancer: emerging understanding of the molecular mechanism
Harpreet Singh, Arun Kumar Mishra, Sourav Mohanto, Arvind Kumar, Amrita Mishra, Ruhul Amin, Chellappan Ronald Darwin, Talha Bin Emran · 2024 · Annals of Medicine and Surgery
Modeling of osteosarcoma with induced pluripotent stem cells
Lon Kai Pang, Mezthly Pena, Ruiying Zhao, Dung‐Fang Lee · 2020 · Stem Cell Research
From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis
Aikaterini F. Giannopoulou, Athanassios D. Velentzas, Athanasios K. Anagnostopoulos, Adamantia Agalou, Nikolaos C. Papandreou, Stamatia A. Katarachia, Dimitra G. Koumoundourou, Eumorphia G. Konstantakou, Vasiliki I. Pantazopoulou, Anastasios D. Delis et al. · 2021 · Cancers
P53 immunolabeling in EUS‐FNA biopsy can predict low resection rate and early recurrence in resectable or borderline resectable pancreatic cancer treated with neoadjuvant therapy
Minoru Oshima, Keiichi Okano, Hideki Kamada, Hironobu Suto, Yasuhisa Ando, Emi Ibuki, Ryou Ishikawa, Tsutomu Masaki, Reiji Haba, Yasuyuki Suzuki · 2022 · Journal of Hepato-Biliary-Pancreatic Sciences
Gd-Metallofullerenol nanoparticles cause intracellular accumulation of PDGFR-α and morphology alteration of fibroblasts
Jinglong Tang, Mengyu Guo, Peng Wang, Jing Liu, Yating Xiao, Wenting Cheng, Jinling Gao, Wenquan Hu, Qing Miao · 2018 · Nanoscale
NF-YA overexpression protects from glutamine deprivation
Diletta Dolfini, Mario Minuzzo, Sarah Sertic, Roberto Mantovani · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
SOX9 Protein in Pancreatic Cancer Regulates Multiple Cellular Networks in a Cell-Specific Manner
E. P. Kopantzev, Liya G. Kondratyeva, Marina R. Kopantseva, К. Н. Кашкин, D. A. Gnatenko, Elizaveta Grigorieva, И. В. Алексеенко, Dina R. Safina, И. П. Чернов · 2022 · Biomedicines
Pseudopterosin and O-Methyltylophorinidine Suppress Cell Growth in a 3D Spheroid Co-Culture Model of Pancreatic Ductal Adenocarcinoma
Bailu Xie, Jan Hänsel, Vanessa Mundorf, Janina Betz, Irene Reimche, Mert Erkan, Ibrahim Büdeyri, Anne Gesell, Russell G. Kerr, Ni Putu Ariantari et al. · 2020 · Bioengineering
Understanding the prowess of mutant p53
Nicola Jane McCarthy · 2014 · Nature reviews. Cancer
Significant pathway and biomarker identification of pancreatic cancer associated lung cancer
Tamanna Khan, Bikash Kumar Paul, M. T. Hasan, Md Rakib Islam, M. Arefin, K. Ahmed, M. K. Islam, M. A. Moni · 2021 · Informatics in Medicine Unlocked
Anlotinib is effective in the treatment of advanced pancreatic cancer: a case report
Shuyi Li, Mengke Niu, Wenying Deng, Ning Li, Chen Wei, Suxia Luo · 2021 · Anti-Cancer Drugs
Genetic Alterations Featuring Biological Models to Tailor Clinical Management of Pancreatic Cancer Patients
Shannon R. Nelson, Naomi Walsh · 2020 · Cancers
A signal-based method for finding driver modules of breast cancer metastasis to the lung
Gaibo Yan, Vicky Chen, Xinghua Lu, Songjian Lu · 2017 · Scientific Reports
Machine learning and gene network integration reveal prognostic subnetworks and biomarkers in pancreatic cancer
Rana Salihoğlu, Jesus Nieves, Gudrun Dandekar, Regina Ebert, Maximilian Rudert, Thomas Dandekar, Elena Bencúrová · 2025 · Computational and Structural Biotechnology Journal
Caffeic acid, a dietary polyphenol, pre-sensitizes pancreatic ductal adenocarcinoma to chemotherapeutic drug
Shruti Gupta, Harshita Tak, Khushhal Rathore, Hemanth Naick Banavath, Kiran Kumar Tejavath · 2024 · Journal of Biomolecular Structure and Dynamics
Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients
Zhongyuan Cui, Ling Du, Jielong Wang, Zhongzhuan Li, Jiehong Xu, Shiyu Ou, Dongliang Li, Shasha Li, Hanfang Hu, Gang Chen et al. · 2022 · BMC Cancer
Recombinant human adenovirus‑p53 improves the outcome of mid‑late stage pancreatic cancer via arterial infusion
Jinggang Mo, Meihua Lin, Bin He, Kai Wei Tan, Chong Jin, Hao Jiang, Xuefeng Pan, Weidong Lin · 2017 · Oncology Letters
Role of p53 family isoforms in enhancing aggressiveness and chemoresistance in pancreatic cancer (Review)
Hossein Jahedi, Aminath Luveysa Fahud, Chooi Ling Lim · 2019 · World Academy of Sciences Journal
Nanomedicine in Pancreatic Cancer: A New Hope for Treatment
Pablo Redruello Guerrero, Gloria Perazzoli, Ana Luisa Cepero, Francisco Quiñonero, Cristina Mesas, Kevin Doello, Antonio Jesús Láinez Ramos‐Bossini, Mario Rivera‐Izquierdo, Consolación Melguizo, Jose Carlos Prados · 2020 · Current Drug Targets
p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator
Joy M. McDaniel, Rhiannon L. Morrissey, Denada Dibra, Lalit R. Patel, Shunbin Xiong, Yun Zhang, Gilda P. Chau, Xiaoping Su, Yuan Qi, Adel K. El‐Naggar et al. · 2024 · Cancer Research Communications
B Cells in the Gastrointestinal Tumor Microenvironment with a Focus on Pancreatic Cancer: Opportunities for Precision Medicine?
Dário Ligeiro, Martin Rao, Andreia Maia, Mireia Castillo-Martín, Antonio Lopez-beltran B, Markus J. Maeurer · 2020 · Advances in experimental medicine and biology
Overexpression of ING3 is associated with attenuation of migration and invasion in breast cancer
Huimeng Li, Hengyu Zhang, Xin Tan, Dequan Liu, Rong Guo, Maohua Wang, Yiyin Tang, Kai Zheng, Wenlin Chen, Hongwan Li et al. · 2021 · Experimental and Therapeutic Medicine
Glioblastoma extracellular vesicles influence glial cell hyaluronic acid deposition to promote invasiveness
Dominik Koessinger, David Novo, Anna L. Koessinger, America V. Campos, Jasmine Peters, Louise R. Dutton, Peggy Paschke, Désirée Zerbst, Madeleine H. Moore, Louise E. Mitchell et al. · 2023 · Neuro-Oncology Advances
KG-SLomics: Synthetic Lethality Prediction Using Knowledge Graph and Cancer Type-Specific Multiomics Integrated Graph Neural Network
Songyeon Lee, Hojung Nam · 2025 · IEEE Transactions on Computational Biology and Bioinformatics
Aptamer affinity to P53 DBD: A molecular dynamics study
Maryam Atabay, Mohammad Reza Ejtehadi · 2023 · Journal of Molecular Structure
Knockout of the gene encoding the extracellular matrix protein SNED1 results in early neonatal lethality and craniofacial malformations
Anna Barqué, Jan, Kyleen, Emanuel De La Fuente, Christina L. Nicholas, Richard O. Hynes, Alexandra Naba · 2020 · DSpace@MIT (Massachusetts Institute of Technology)
Knockout of the gene encoding the extracellular matrix protein SNED1 results in early neonatal lethality and craniofacial malformations
Anna Barqué, Kyleen Jan, Emanuel De La Fuente, Christina L. Nicholas, Richard O. Hynes, Alexandra Naba · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
Epigenetic and transcriptional control of classical and basal-like cell states in pancreatic ductal adenocarcinoma
Christina Parassiadis, Steven A. Johnsen · 2026 · Gastroenterology report
Pathobiology of pancreatic cancer: implications on therapy
Ivonne Regel, Simone Hausmann, Simone Benitz, Iréne Esposito, Jorg H. Kleeff · 2015 · Expert Review of Anticancer Therapy
AMPK Is the Crucial Target for the CDK4/6 Inhibitors Mediated Therapeutic Responses in PANC-1 and MIA PaCa-2 Pancreatic Cancer Cell Lines
Börteçine Sevgin, Merve Coban, Özge Rencüzoğulları, Ajda Çoker Gürkan, Pınar Obakan Yerlikaya, Pinar Uysal Onganer, Elif Damla Arısan · 2021 · Stresses
The G199X and V157fs mutations in the TP53 gene promote malignancy in serous ovarian cancer: an analysis using whole-exome sequencing
Dan Su, Man Nie, Jun Yue · 2021 · Annals of Translational Medicine
2-(4-Benzyloxy-3-methoxyphenyl)-5-(carbethoxyethylene)-7-methoxy-benzofuran, a Benzofuran Derivative, Suppresses Metastasis Effects in P53-Mutant Hepatocellular Carcinoma Cells
Tsui‐Hwa Tseng, Yi-Chia Shao, Yean‐Jang Lee, Huei‐Jane Lee · 2023 · Biomedicines
The anti-tumor effect of trifluridine via induction of aberrant mitosis is unaffected by mutations modulating p53 activity
Takeshi Wakasa, Kentaro Nonaka, Akihito Harada, Yasuyuki Ohkawa, Chie Kikutake, Mikita Suyama, Takashi Kobunai, Kenta Tsunekuni, Kazuaki Matsuoka, Yuki Kataoka et al. · 2024 · Cell Death Discovery
Mutant p53 regulates a distinct gene set by a mode of genome occupancy that is shared with wild type
Ramy Rahmé, Lois Resnick‐Silverman, Vincent Anguiano, Moray J. Campbell, Pierre Fenaux, James J. Manfredi · 2025 · EMBO Reports
Data mining and manual curation of published microarray datasets to establish a multi-gene panel for prediction of liver metastasis
Kanisha Shah, Shanaya Patel, Sheefa Mirza, Apexa P. Raval, Rakesh Rawal · 2016 · Meta Gene
Introduction to Genes, Oncogenes, and Anti-oncogenes
Undurti Narasimha Das · 2020 · Springer eBooks
Rab11-FIP1/RCP Functions as a Major Signalling Hub in the Oncogenic Roles of Mutant p53 in Cancer
Yannick von Grabowiecki, Vinaya M. Phatak, Lydia Aschauer, Patricia A. J. Muller · 2021 · Frontiers in Oncology
Recent Advances, New Perspectives and Applications in the Treatment of Ovarian Cancer
Michael Friedrich · 2022 · IntechOpen eBooks
Druggable sites/pockets of the p53-DNAJA1 protein–protein interaction: In silico modeling and in vitro/in vivo validation
Danielle R. Jacobsen, Omar Bushara, Rama K. Mishra, Leyu Sun, Jie Liao, Guang‐Yu Yang · 2022 · Methods in enzymology on CD-ROM/Methods in enzymology
Targeted Therapies for Pancreatic Cancer
Michael S. Lee, Shubham Pant · 2023 · Springer eBooks
Assessment of PDGFRβ promoter methylation in canine osteosarcoma using methylation‐sensitive high‐resolution melting analysis
Fabio Gentilini, Ombretta Capitani, Debora Tinto, Antonella Rigillo, Silvia Sabattini, Giuliano Bettini, Elena Turba Maria · 2020 · Veterinary and Comparative Oncology
PDX1 directs a core developmentally and evolutionarily conserved gene program in the pancreatic islet
Xiaodun Yang, Jeffrey C. Raum, Junil Kim, Reynold Yu, Juxiang Yang, Gabriella Rice, Changhong Li, Kyoung‐Jae Won, Doris A. Stoffers, Diana E. Stanescu · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Eradicating Cancer Stem Cells Using High Linear Energy Transfer Radiation Therapy Part 1: Physics and Radiobiology
Daniel M. Koffler, Daniel K. Ebner, Eric J. Lehrer, Fatemeh Fekrmandi, Felix Ehret, Morteza Mahmoudi, Chris J Beltran, Daniel Michael Trifiletti, Laura A. Vallow, Michael Scott Rutenberg et al. · 2025 · Applied Radiation Oncology
The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma
Carlotta Zampieri, Kourosh Kouhmareh, Parnian Sartipdolagh, Pardis Azmoon, Richard L. Klemke, Steven L. Gonias · 2025 · Journal of Biological Chemistry
Mutant p53 regulates reversible subtype plasticity in pancreatic cancer
June-Ha Shin, Hwa-Ryeon Kim, Jae‐Seok Roe · 2025 · Cellular and Molecular Life Sciences
Cell Cycle Machinery and Its Alterations in Pancreatic Cancer
Yusuke Kojima, Reeja S. Maskey, Yuichi Machida · 2018 · Springer eBooks
Alive failures behind the windows of cancer therapy
Muhammad Torequl Islam · 2017 · International Journal of Medicine